NDC 70436-151
Arformoterol Tartrate Inhalation
Arformoterol Tartrate Inhalation
Arformoterol Tartrate Inhalation is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Slate Run Pharmaceuticals. The primary component is Arformoterol Tartrate.
Product ID | 70436-151_27a1ba65-5029-462a-8e6e-5ac1056e6c72 |
NDC | 70436-151 |
Product Type | Human Prescription Drug |
Proprietary Name | Arformoterol Tartrate Inhalation |
Generic Name | Arformoterol Tartrate Inhalation |
Dosage Form | Solution |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 2021-06-22 |
Marketing Category | ANDA / |
Application Number | ANDA213762 |
Labeler Name | Slate Run Pharmaceuticals |
Substance Name | ARFORMOTEROL TARTRATE |
Active Ingredient Strength | 15 ug/2mL |
Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |